Disappointing News for Urologists Managing Interstitial Cystitis Patients

[摘要] Data supporting effective therapies for interstitial cystitis (IC) are scarce. The year 2005 started out with so much promise. Reports were going to be published that would announce the results of 3 promising intravesical therapies: alkalinization, Bacillus Calmette-Guérin (BCG), and resiniferatoxin (RTX). But the promises of these novel, exciting approaches to the management of IC were dashed against the bulwarks of evidence from randomized, placebo-controlled trials.

[学科分类] 基础医学